Evidence map›Paper›PMID 38698045›Full record

ArticleScientific reports2024

COPII cage assembly factor Sec13 integrates information flow regulating endomembrane function in response to human variation.

Frédéric Anglès, Vijay Gupta, Chao Wang, William E Balch

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.International journal of molecular sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Frédéric AnglèsDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA, 92037, USA.
Vijay GuptaDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA, 92037, USA.
Chao WangDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA, 92037, USA.
William E BalchDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA, 92037, USA. webalch@scripps.edu.

Funding

Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI NAVDEEP S CHANDEL · 2015 to 2026
$26.9M
Restoration of mutant CFTR stability and functionR01DK051870 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BALCH, WILLIAM EDWARD · 1996 to 2020
$8.7M
Modulation of Lung Disease by Genetic/Epigenetic ProfilingR01HL095524 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI William Edward Balch · 2010 to 2026
$7.5M
Genotype First: Actionable Genetic Risk through Genotype-to-Phenotype PredictionR01HG010881 · NHGRI · SCRIPPS RESEARCH INSTITUTE, THE · PI TORKAMANI, ALI · 2020 to 2023
$3.1M
Using Genetic Diversity to Manage Neurological DiseaseR01AG070209 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI BALCH, WILLIAM EDWARD · 2021 to 2025
$2.7M
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling PathwaysR01HL169631 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI William Edward Balch · 2024 to 2026
$2.6M
Managing the Folding Landscape in Alpha1 Liver-Lung DiseaseR01HL141810 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI BALCH, WILLIAM EDWARD · 2018 to 2021
$1.9M
Applying Spatial Covariance to Understand Human Variation in Genetic DiseaseR01HL166410 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI William Edward Balch · 2023 to 2026
$1.8M
NHGRI NIH HHS R01 HG010881NHLBI NIH HHS R01 HL095524NHLBI NIH HHS R01 HL141810NHLBI NIH HHS R01 HL166410NHLBI NIH HHS R01 HL169631NIA NIH HHS P01 AG049665NIA NIH HHS R01 AG070209NIDDK NIH HHS R01 DK051870NIH HHS AG049665NIH HHS AG070209NIH HHS DK051870NIH HHS HG10881NIH HHS HL141810NIH HHS NIH HL095524
6 · The paper itself

Abstract

How information flow is coordinated for managing transit of 1/3 of the genome through endomembrane pathways by the coat complex II (COPII) system in response to human variation remains an enigma. By examining the interactome of the COPII cage-assembly component Sec13, we show that it is simultaneously associated with multiple protein complexes that facilitate different features of a continuous program of chromatin organization, transcription, translation, trafficking, and degradation steps that are differentially sensitive to Sec13 levels. For the trafficking step, and unlike other COPII components, reduction of Sec13 expression decreased the ubiquitination and degradation of wild-type (WT) and F508del variant cargo protein cystic fibrosis transmembrane conductance regulator (CFTR) leading to a striking increase in fold stability suggesting that the events differentiating export from degradation are critically dependent on COPII cage assembly at the ER Golgi intermediate compartment (ERGIC) associated recycling and degradation step linked to COPI exchange. Given Sec13's multiple roles in protein complex assemblies that change in response to its expression, we suggest that Sec13 serves as an unanticipated master regulator coordinating information flow from the genome to the proteome to facilitate spatial covariant features initiating and maintaining design and function of membrane architecture in response to human variation.

Indexed as

Carrier ProteinsCOP-Coated VesiclesCystic Fibrosis Transmembrane Conductance RegulatorProtein TransportVesicular Transport ProteinsEndoplasmic ReticulumGolgi ApparatusHumansProteolysisUbiquitinationCarrier ProteinsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorSEC13 protein, humanVesicular Transport Proteins

Identifiers

PMID38698045
PMCPMC11065896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.